Takotsubo Syndrome in a Patient With a Malignant Tumor of the Kidney
https://doi.org/10.23934/2223-9022-2020-9-1-148-158
Abstract
RELEVANCE. The increasing availability of invasive methods for assessing the coronary vessels contributes to the growth in the diagnosis of myocardial damage in intact coronary arteries. One of the least studied diseases that mimic the course of myocardial infarction is Takotsubo syndrome, which quite often remains undiagnosed in real clinical practice. The medical and economic significance of this disease is determined by the high risk of developing life-threatening complications and the need to provide emergency specialized medical care.
AIM OF STUDY. The paper presents an analytical review of scientific medical literature from the perspective of illustrating modern concepts of the most common risk factors, etiopathogenesis, diagnosis and treatment of Takotsubo syndrome. A clinical observation of a patient with verified secondary Takotsubo syndrome against a malignant neoplasm of the kidney is also presented.
CONCLUSIONS. For a detailed understanding of the potential mechanisms for the development of Takotsubo syndrome, determining the most informative methods for its diagnosis, developing effective strategies for providing medical care and criteria for long-term prognosis, further large-scale studies are needed. Raising the level of awareness of doctors about Takotsubo syndrome, in turn, will allow timely detection of this disease, which will improve the prognosis for patients and minimize the economic costs of treatment. The exclusion of the possibility of overdiagnosis will also help determine the true prevalence of this disease.
About the Authors
N. V. RutkovskayaRussian Federation
Natalya V. Rutkovskaya, Doctor of Medical Sciences, Head of the Center for Cardiology, Head
Y. N. Lazarenko
Russian Federation
Clinical Resident of the Department of Therapy of the Biomedical University of Innovation and Continuing Education
S. R. Shtin
Russian Federation
Candidate of Medical Sciences, Head of the Intensive Care Unit, Anesthesiologist and Resuscitator
A. S. Samoylov
Russian Federation
Doctor of Medical Sciences, Professor of the Russian Academy of Sciences, Associate Professor, General Director
A. V. Sotnikov
Russian Federation
Doctor of Medical Sciences, Head of the Center for Anesthesiology, Resuscitation and Intensive Care, Head of the Department of Anesthesiology and Reanimation No. 2
E. A. Praskurnichy
Russian Federation
Doctor of Medical Sciences, Professor, Head of the Department of Therapy, Medical and Biological University of Innovation and Continuing Education
O. V. Parinov
Russian Federation
Candidate of Medical Sciences, Deputy Chief Physician for Therapy, Head of the Therapeutic Department, Gastroenterologist
Y. D. Udalov
Russian Federation
Candidate of Medical Sciences, Associate Professor, Deputy General Director for Medicine
References
1. Lyon A, Bossone E, Schneider B, Sechtem U, Citro R, Underwood SR, et al. Current state of knowledge on Takotsubo syndrome: a position statement from the taskforce on Takotsubo syndrome of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2016;18(1):8–27. PMID: 26548803 https://doi.org/10.1002/ejhf.424
2. Deshmukh A, Kumar G, Pant S, Rihal C, Murugiah K, Mehta JL. Prevalence of Takotsubo cardiomyopathy in the United States. Am Heart J. 2012;164(1):66–71. PMID: 22795284 https://doi.org/10.1016/j.ahj.2012.03.020
3. Brinjikji W, El-Sayed AM, Salka S. In-hospital mortality among patients with takotsubo cardiomyopathy: a study of the National Inpatient Sample 2008 to 2009. Am Heart J. 2012;164(2):215–221. PMID: 22877807 HTTPS://DOI.ORG/10.1016/J.AHJ.2012.04.010
4. Abdrakhmanova AI, Tsibulkin NA, Amirov NB, Galimzyanova LA, Saifullina GB, Oslopova JuV. Tacotsubo syndrome in the course of internal diseases. The Bulletin of Contemporary Clinical Medicine. 2017;10(6):49–60. (In Russ.) https://doi.org/10.20969/vskm.2017.10(6).49–60
5. Pelliccia F, Kaski JC, Crea F, Camici PG. Pathophysiology of Takotsubo syndrome. Circulation. 2017;135(24):2426–2441. PMID: 28606950 https://doi.org/10.1161/circulationaha.116.027121
6. Citro R, Rigo F, Previtali M, Ciampi Q, Canterin FA, Provenza G, et al. Differences in clinical features and inhospital outcomes of older adults with takotsubo cardiomyopathy. J Am Geriatr Soc. 2012;60(1):93–98. PMID: 22092251 https://doi.org/10.1111/j.1532-5415.2011.03730.x
7. da Silva Costa IBS, Figueiredo CS, Fonseca SM, Bittar CS, de Carvalho Silva CMD, Rizk SI, et al. Takotsubo syndrome: an overview of pathophysiology, diagnosis and treatment with emphasis on cancer patients. Heart Fail Rev. 2019;24(6):833–846. PMID: 31197563 https://doi.org/10.1007/s10741-019-09813-1
8. Schneider B, Athanasiadis A, Stollberger C, Pistner W, Schwab J, Gottwald U, et al. Gender differences in the manifestation of Тakotsubo cardiomyopathy. Int J Cardiol. 2013; 166(3):584–588. PMID: 22192296 https://doi.org/10.1016/j.ijcard.2011.11.027
9. Shmotkina AO, Shilova AS, Giliarova EM, Bakradze LM, Giliarov MYu. Takotsubo syndrome in critically ill patients in a Moscow multifield hospital. Russian Journal of Anаеsthesiology and Reanimatology. 2019;(1):44–49. (In Russ.) https://doi.org/10.17116/anaesthesiology201901144
10. Wan SH, Liang JJ. Takotsubo cardiomyopathy: etiology, diagnosis, and optimal management. Res Rep Clin Cardiol. 2014;5:297–303. https://doi.org/10.2147/rrcc.s46021
11. Paur H, Wright PT, Sikkel MB, Tranter MH, Mansfield C, O’Gara P, et al. High levels of circulating epinephrine trigger apical cardiodepression in a β2-adrenergic receptor/ Gi-dependent manner: a new model of Takotsubo cardiomyopathy. Circulation. 2012;126(6):697–706. PMID: 22732314 https://doi.org/10.1161/circulationaha.112.111591
12. Gianni M, Dentali F, Grandi AM, Sumner G, Hiralal R, Lonn E. Apical ballooning syndrome or Takotsubo cardiomyopathy: a systematic review. Eur Heart J. 2006; 27(13):1523–1529. PMID: 16720686. https://doi.org/10.1093/eurheartj/ehl032
13. Kassim TA, Clarke DD, Mai VQ, Clyde PW, Mohamed Shakir KM. Catecholamine-induced cardiomyopathy. Endocr Pract. 2008;14(9):1137–1149. PMID: 19158054 https://doi.org/10.4158/ep.14.9.1137
14. Moiseeva OM. Myocardites: basic principles of diagnostics and treatment. Cardiology: News, Opinions, Training. 2016;1(8):48–59. (In Russ.)
15. Caforio AL, Calabrese F, Angelini A, Tona F, Vinci A, Bottaro S, et al. A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur Heart J. 2007;28(11):1326–1333. PMID: 17493945 https://doi.org/10.1093/eurheartj/ehm076
16. Sasaki, Nishioka T, Akima T, Tabata H, Okamoto Y, Akanuma M, et al. Association of Тakotsubo cardiomyopathy and long QT syndrome. Circ J. 2006; 70(9):1220–1222. PMID: 16936440 https://doi.org/10.1253/circj.70.1220
17. Pezzo SP, Hartlage G, Edwards CM. Takotsubo cardiomyopathy presenting with dyspnea. J Hosp Med. 2009;4(3):200–202. PMID: 19301382 https://doi.org/10.1002/jhm.402
18. Bahlmann E, Krause K, Häerle T, van der Schalk H, Kuck KH. Cardiac arrest and successful resuscitation in a patient with Tako-Tsubo Cardiomyopathy. Int J Cardiol. 2008;130(1):4–6. PMID: 18703242 https://doi.org/10.1016/j.ijcard.2008.06.065
19. Legriel S, Bruneel F, Dalle L, Appere-de-Vecchi C, Georges JL, Abbosh N, et al. Recurrent takotsubo cardiomyopathy triggered by convulsive status epilepticus. Neurocrit Care. 2008;9(1):118–121. PMID: 18506637 https://doi.org/10.1007/s12028-008-9107-6
20. Abe Y, Tamura A, Kadota J. Prolonged cardiogenic shock caused by a high-dose intravenous administration of dopamine in a patient with takotsubo cardiomyopathy. Int J Cardiol. 2010;141(1):e1–3. PMID: 19135739 https://doi.org/10.1016/j.ijcard.2008.11.123
21. Templin C, Ghadri JR, Diekmann J, Napp LC, Bataiosu DR, Jaguszewski M, et al. Clinical features and outcomes of Takotsubo (stress) cardiomyopathy. New Engl J Med. 2015;373(10):929–938. PMID: 2633254 https://doi.org/10.1056/nejmoa1406761
22. Madias JE. Transient attenuation of the amplitude of the QRS complexes in the diagnosis of Takotsubo syndrome. Eur Heart J Acute Cardiovasc Care. 2014;3(1):28–36. PMID: 24562801 https://doi.org/10.1177/2048872613504311
23. Litvinenko RI, Shulenin SN, Kulikov AN, Nagorny MB, Bobrov AL, Shloido EA, et al. The differential diagnosis of transient myocardial ischemia – takotsubo-cardiomyopathy. Vestnik Rossiiskoi Voenno-Medicinskoi Academii. 2013;1(41):84–93. (In Russ.)
24. Citro R, Rigo F, Ciampi Q, D’Andrea A, Provenza G, Mirra M, et al. Echocardiographic assessment of regional left ventricular wall motion abnormalities in patients with takotsubo cardiomyopathy: comparison with anterior myocardial infarction. Eur J Echocardiogr. 2011;12(7):542–549. PMID: 21606046 https://doi.org/10.1093/ejechocard/jer059
25. Shah BN, Curzen NP. Reversible systolic anterior motion of the mitral valve and left ventricular outflow tract obstruction in association with Takotsubo syndrome. Echocardiography. 2011;28(8):921–924. PMID: 21827539 https://doi.org/10.1111/j.1540-8175.2011.01446.x
26. Gaibazzi N, Ugo F, Vignali L, Zoni A, Reverberi C, Gherli T, et al. Tako- Tsubo cardiomyopathy with coronary artery stenosis: a case-series challenging the original definition. Int J Cardiol. 2009; 133(2):205–212. PMID: 18313156 https://doi.org/10.1016/j.ijcard.2007.12.037
27. Previtali M, Repetto A, Panigada S, Camporotondo R, Tavazzi L. Left ventricular apical ballooning syndrome: prevalence, clinical characteristics and pathogenetic mechanisms in a European population. Int J Cardiol. 2009; 134(1):91–96. PMID: 18508143 https://doi.org/10.1016/j.ijcard.2008.01.037
28. Haghi D, Roehm S, Hamm K, Harder N, Suselbeck T, Borggrefe M, et al. Takotsubo cardiomyopathy is not due to plaque rupture: an intravascular ultrasound study. Clin Cardiol. 2010;33(5):307–310. PMID: 20513070 https://doi.org/10.1002/clc.20747
29. Eitel I, von Knobelsdorff-Brenkenhoff F, Bernhardt P, Carbone I, Muellerleile K, Aldrovandi A, et al. Clinical characteristics and cardiovascular magnetic resonance findings in stress (takotsubo) cardiomyopathy. JAMA. 2011; 306(3):277–286. PMID: 21771988 https://doi.org/10.1001/jama.2011.992
30. Singh K, Parsaik A, Singh B. Recurrent takotsubo cardiomyopathy: variable pattern of ventricular involvement. Herz. 2014;39(8):963–967. PMID: 23880950 https://doi.org/10.1007/s00059-013-3896-x
31. Palla AR, Dande AS, Petrini J, Wasserman HS, Warshofsky MK, et al. Pretreatment with low-dose beta-adrenergic antagonist therapy does not affect severity of Takotsubo cardiomyopathy. Clin Cardiol. 2012;35(8):478–481. PMID: 22447571 https://doi.org/10.1002/clc.21983
32. Buja P, Zuin G, Di Pede F, Madalosso M, Grassi G, Celestre M, et al. Long-term outcome and sex distribution across ages of left ventricular apicalballooning syndrome. J Cardiovasc Med (Hagerstown). 2008;9(9):905–909. PMID: 18695427 https://doi.org/10.2459/jcm.0b013e3282fec072
33. Liang JJ, Cha YM, Oh JK, Prasad A. Sudden cardiac death: an increasingly recognized presentation of apical ballooning syndrome (Takotsubo cardiomyopathy). Heart Lung. 2013;42(4):270–272. PMID: 18695427 https://doi.org/10.1016/j.hrtlng.2013.04.003
34. Santoro F, Ieva R, Musaico F, Ferraretti A, Triggiani G, Tarantino N, et al. Lack of efficacy of drug therapy in preventing takotsubo cardiomyopathy recurrence: a meta-analysis. Clin Cardiol. 2014;37(7):434–439. PMID: 24700369 https://doi.org/10.1002/clc.22280
35. Singh K, Carson K, Usmani Z, Sawhney G, Shah R, Horowitz J, et al. Systematic review and meta-analysis of incidence and correlates of recurrence of Takotsubo cardiomyopathy. Int J Cardiol. 2014;174(3):696–701. PMID: 24809923 https://doi.org/10.1016/j.ijcard.2014.04.221
Review
For citations:
Rutkovskaya N.V., Lazarenko Y.N., Shtin S.R., Samoylov A.S., Sotnikov A.V., Praskurnichy E.A., Parinov O.V., Udalov Y.D. Takotsubo Syndrome in a Patient With a Malignant Tumor of the Kidney. Russian Sklifosovsky Journal "Emergency Medical Care". 2020;9(1):148-158. https://doi.org/10.23934/2223-9022-2020-9-1-148-158